Patent Assignment
Reel/Frame 023861/0349
Change of Name
Recorded: 2010-01-28
Received: 2010-01-28
Pages: 29
Assignor
MERCK & CO., INC.
Executed: 2009-11-02
Assignee
MERCK SHARP & DOHME CORP.
126 EAST LINCOLN AVENUE, RAHWAY, NJ, 07065, UNITED STATES
Covered Properties
(100)
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Application:
11/496,338 →
Substituted Bicyclic Pyrimidinones as a Mitotic Kinesin Ksp Inhibitors
Application:
11/410,341 →
Benzodiazepine Cgrp Receptor Antagonists
Application:
10/562,298 →
Estrogen Receptor Modulators
Application:
11/261,692 →
Inhibitors of Akt Activity
Application:
11/234,784 →
Aryl Spirohydantoin Cgrp Receptor Antagonists
Application:
10/547,227 →
Monocyclic Anilide Spirohydantoin Cgrp Receptor Antagonists
Application:
10/547,082 →
Tetrahydropyranyl Cyclopentyl Tetrahydroisoquinoline Modulators of Chemokine Receptor Activity
Application:
10/512,925 →
Lactam Tachykinin Receptor Antagonists
Application:
11/135,240 →
Phenylcarboxamide Beta-Secretase Inhibitors for the Treatment of Alzheimer's Disease
Application:
10/534,291 →
Fused Heterobicyclo Substituted Phenyl Metabotropic Glutamate-5 Modulators
Application:
10/527,044 →
Indoles Having Anti-Diabetic Activity
Application:
10/524,697 →
N-Biarylmethyl Aminocycloalkanecarboxamide Derivatives
Application:
10/523,911 →
Therapeutic Compounds for Treating Dyslipidemic Conditions
Application:
10/522,114 →
Substituted Furo[2,3-B]Pyridine Derivatives
Application:
10/521,821 →
Metabotropic Glutamate Receptor-5 Modulators
Application:
10/497,452 →
Tyrosine Kinase Inhibitors
Application:
10/512,927 →
Human Papillomavirus Multiplexed Assay
Application:
10/513,088 →
Estrogen Receptor Modulators
Application:
10/512,172 →
Fluorinated 4-Azasteroid Derivatives as Androgen Receptor Modulators
Application:
10/507,239 →
N-Biphenylmethyl Aminocycloalkanecarboxamide Derivatives
Application:
10/503,502 →
Cyclopentyl Modulators of Chemokine Receptor Activity
Application:
10/901,414 →
Beta-Secretase Substrates and Uses Thereof
Application:
10/480,954 →
Beta-Amino Heterocyclic Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Application:
10/501,059 →
Modulators of Acetylcholine Receptors
Application:
10/500,516 →
Crystal Forms of (-)-6-Chloro-4-Cyclopropylethynyl-4-Trifluoromethyl-1,4-Dihydro-2H-3,1-Benzoxazin-2-One
Application:
10/891,749 →
Heteroaryl Substituted Triazole Modulators of Metabotropic Glutamate Receptor-5
Application:
10/499,391 →
Staphylococcus Aureus Exopolysaccharide and Process
Application:
10/498,070 →
2-Aminoquinoline Compounds
Application:
10/496,615 →
Cgrp Receptor Antagonists
Application:
10/838,835 →
Androgen Receptor Modulators and Methods of Use Thereof
Application:
10/493,013 →
Mass Spectrometry Data Analysis Techniques
Application:
10/814,474 →
Isolated Dna Molecules Encoding Humanized Calcitonin Gene-Related Peptide Receptor, Related Non-Human Transgenic Animals and Assay Methods
Application:
10/490,594 →
Isolated Nucleic Acid Molecules Encoding a Bacterial Uracil Transport Protein and a Bacterial Uracil Phosphoribosyl-Transferase Enzyme, Cells Transformed Therewith and Uses Thereof
Application:
10/490,463 →
Tyrosine Kinase Inhibitors
Application:
10/489,647 →
Tyrosine Kinase Inhibitors
Application:
10/489,594 →
Histamine Receptor H4 Polynucleotides
Application:
10/488,421 →
Acylated Piperazine Derivatives as Melanocortin-4 Receptor Agonists
Application:
10/788,859 →
Tyrosine Kinase Ihnibitors
Application:
10/487,589 →
Gamma Three Protease
Application:
10/486,265 →
Benzimisazo[4,5-F]Isoquinolinone Derivatives
Application:
10/485,720 →
Tyrosine Kinase Inhibitors
Application:
10/485,296 →
Process for the Synthesis of 1-(3,5-Bis(Trifluoromethyl)-Phenyl)Ethan-1-One
Application:
10/451,293 →
Crystalline Forms of Carbapenem Antibiotics and Methods of Preparation
Application:
10/485,319 →
Process for Making Carbapenem Compounds
Application:
10/485,134 →
Radiolabeled Neuropeptide Y Y5 Receptor Antagonists
Application:
10/484,551 →
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Application:
10/250,873 →
Bridged Piperidine Derivatives as Melanocortin Receptor Agonists
Application:
10/483,913 →
Beta-Amino Tetrahydroimidazo (1, 2-a) Pyrazines and Tetrahydrotrioazolo (4,3-a) Pyrazines as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Application:
10/481,353 →
Phenylalanine Derivatives as Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Application:
10/481,352 →
Dipeptidyl Peptidase Inhibitors for the Treatment of Diabetes
Application:
10/481,319 →
Triazole Derivatives as Inhibitors of 11-Beta-Hydroxysteroid Dehydrogenase-1
Application:
10/739,716 →
Process for Producing Activated Thrombin-Activatable Fibrinolysis Inhibitor
Application:
10/736,793 →
Synthetic Virus-Like Particles with Heterologous Epitopes
Application:
10/737,528 →
Process to Ribofuranose Sugar Derivatives as Intermediates to Branched-Chain Nucleosides
Application:
10/729,105 →
Reductive Alkylation of Saturated Cyclic Amines
Application:
10/726,091 →
(Pyrimidinyl) (Phenyl) Substituted Fused Heteroaryl P38 Inhibiting and Pkg Kinase Inhibiting Compounds
Application:
10/477,367 →
Cyanothiophene Derivatives, Compositions Containing Such Compounds and Methods of Use
Application:
10/701,186 →
Dna Molecules Encoding Macaca Mulatta Androgen Receptor
Application:
10/476,724 →
11-Beta-Hydroxysteroid Dehydrogenase 1 Inhibitors Useful for the Treatment of Diabetes, Obesity and Dyslipidemia
Application:
10/697,547 →
Benzazepinone Alpha Vintegrin Receptor Antagonists
Application:
10/475,697 →
Nucleoside Derivatives as Inhibitors of Rna-Dependent Rna Viral Polymerase
Application:
10/688,691 →
Ophthalmic Compositions for Treating Ocular Hypertension
Application:
10/684,990 →
Process for the Synthesis of Trifluorophenylacetic Acids
Application:
10/680,025 →
Tyrosine Kinase Inhibitors
Application:
10/677,687 →
Inhibitors of Akt Activity
Application:
10/473,788 →
Inhibitors of Akt Activity
Application:
10/473,785 →
Dipeptidyl Peptidase Inhibitors for the Treatment or Prevention of Diabetes
Application:
10/472,771 →
Aza-And Polyaza-Naphthalenyl-Carboxamides Useful as Hiv Integrase Inhibitors
Application:
10/399,083 →
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
Application:
10/468,517 →
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
Application:
10/468,515 →
Nitrogen-Containing Compounds and Their Use as Glycine Transport Inhibitors
Application:
10/344,962 →
Thrombin Inhibitors
Application:
10/467,439 →
Novel Alicylic Imidazoles as H3 Agents
Application:
10/344,787 →
2-Aryloxy-2ARYLALKANOIC Acids for Diabetes and Lipid Disorders
Application:
10/470,954 →
Acyl Sulfamides for Treatment of Obesity, Diabetes and Lipid Disorders
Application:
10/470,483 →
Production of Chimeric Human Papillomavirus
Application:
10/332,553 →
Pyrrolidine Modulators of CCR5 Chemokine Receptor Activity
Application:
10/399,084 →
Ophthalmic Compositions for Treating Ocular Hypertension
Application:
10/466,878 →
Process for Carbapenem Synthesis
Application:
10/466,876 →
Polymorphs with Tyrosine Kinase Activity
Application:
10/607,091 →
11-Beta-Hydroxysteroid Dehydrogenase 1 Inhibitors Useful for the Treatment of Diabetes, Obesity and Dyslipidemia
Application:
10/457,682 →
Process for Making Substituted 8-Arylquinolinium Benzenesulfonate
Application:
10/433,538 →
Thrombin Inhibitors
Application:
10/427,435 →
Assays Using Amyloid Precursor Proteins with Modified Beta-Secretase Cleavage Sites to Monitor Beta-Secretase Activity
Application:
10/427,208 →
Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators of Chemokine Receptor Activity
Application:
10/425,167 →
Mammalian Metabolites of a Tachykinin Receptor Antagonist
Application:
10/415,205 →
Neuromedin U Receptor NMUR2 and Nucleotides Encoding It
Application:
10/258,423 →
Substituted Amides
Application:
10/387,265 →
Isoquinolinone Potassium Channels Inhibitors
Application:
10/362,484 →
Anti-hypercholesterolemic drug combination
Application:
10/344,591 →
Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
Application:
10/356,879 →
Iodohydroxylation of Olefins
Application:
10/356,056 →
N-Biphenyl(Substituted Methyl) Aminocycloalkane-Carboxamide Derivatives
Application:
10/354,674 →
Process for Making Spirolactone Compounds
Application:
10/349,835 →
Human Neuronal Nicotinic Acetylcholine Receptor Compositions and Methods Employing Same
Application:
10/349,836 →
Dog Melanin-Concentrating Hormone Receptor
Application:
10/333,379 →
5-Chloro-3-(4-Methanesulfonylphenyl)-6'-Methyl-[2,3']Bipyridinyl in Pure Crystalline Form and Process for Synthesis
Application:
10/342,380 →
Process for the Synthesis of (R)-1-(3,5-Bis(Trifluoromethyl)-Phenyl)Ethan-1-Ol by Asymmetric Transfer Hydrogenation
Application:
10/324,956 →
Isoforms of Mouse Serotonin 5-HT2C Receptor
Application:
10/280,858 →